In one paragraphArticle in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
25 authors.
MD Anderson Head and Neck Cancer Symptom Working Group
Serageldin KamelThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0002-0046-4337 Laia Humbert-VidanThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0002-8005-6770 Zaphanlene KaffeyThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0009-0008-7999-5245 Abdulrahman AbusaifThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.
David T A FuentesThe University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA.ORCID 0000-0002-2572-6962 Kareem WahidThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0002-0503-0175 Cem DedeThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0002-0543-9325 Mohamed A NaserThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0003-1020-4966 Renjie HeThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0001-9166-6286 Ahmed W MoawadThe University of Texas MD Anderson Cancer Center, Division of Radiology, Houston, USA.
Khaled M ElsayesThe University of Texas MD Anderson Cancer Center, Division of Radiology, Houston, USA.
Melissa M ChenThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0002-3274-2653 Adegbenga O OtunThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0001-7599-1628 Jillian RigertThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0001-5419-980X Mark ChambersThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0001-8901-6583 Kristy K BrockThe University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA.ORCID 0000-0001-9364-5040 Lisanne van DijkThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery, Houston, USA.ORCID 0000-0002-9515-5616 Amy C MorenoThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0001-6762-6807 Stephen Y LaiThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0001-8301-7286 Clifton D FullerThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0002-5264-3994 Abdallah S R MohamedThe University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, USA.ORCID 0000-0003-2064-7613 Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8MEarly Detection of Hepatocellular CarcinomaR01CA195524 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAURA BERETTA, David Fuentes · 2016 to 2026
$6.5MDevelopment of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3MUsing Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9MLongitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer TherapyR01CA258827 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CANAHUATE, GUADALUPE, FULLER, CLIFTON DAVID · 2021 to 2025
$2.9MQuantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)U01DE032168 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Clifton David Fuller, STEPHEN Y LAI · 2023 to 2026
$2.8MSCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8MImage Guided Cancer Therapy Training ProgramT32CA261856 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kristy Brock, Clifton David Fuller · 2022 to 2026
$1.2MProbabilistic Deep Learning Cervical Lymph-Node Auto-Segmentation For Imaging-enhanced Evaluation of Extracapsular Extension Risk (PDL-CLASIFIER)R03DE033550 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, NASER, MOHAMED · 2024 to 2025
$499kProvider and Patient-generated Remote Oro-Dental Health Electronic Data Capture for Algorithmic Longitudinal Evaluation and Risk-Assessment (PROHEALER)K01DE030524 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORENO, AMY CATHERINE · 2022 to 2024
$479kMultiparametric Magnetic Resonance Imaging Artificial Intelligence Pipeline for Oropharyngeal Cancer Radiotherapy Treatment GuidanceF31DE031502 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WAHID, KAREEM · 2021 to 2023
$68kNCI NIH HHS P30 CA016672NCI NIH HHS R01 CA195524NCI NIH HHS R01 CA257814NCI NIH HHS R01 CA258827NCI NIH HHS T32 CA261856NIDCR NIH HHS F31 DE031502NIDCR NIH HHS K01 DE030524NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R03 DE033550NIDCR NIH HHS U01 DE032168
6 · The paper itselfAbstract
Purpose: This study aims to identify radiomic features extracted from contrast-enhanced CT scans that differentiate osteoradionecrosis (ORN) from normal mandibular bone in patients with head and neck cancer (HNC) treated with radiotherapy (RT). Materials and Methods: Contrast-enhanced CT (CECT) images were collected for 150 patients (80% train, 20% test) with confirmed ORN diagnosis at The University of Texas MD Anderson Cancer Center between 2008 and 2018. Using PyRadiomics, radiomic features were extracted from manually segmented ORN regions and the corresponding automated control regions, the later defined as the contralateral healthy mandible region. A subset of pre-selected features was obtained based on correlation analysis (r > 0.95) and used to train a Random Forest (RF) classifier with Recursive Feature Elimination. Model explainability SHapley Additive exPlanations (SHAP) analysis was performed on the 20 most important features identified by the trained RF classifier. Results: From a total of 1316 radiomic features extracted, 810 features were excluded due to high collinearity. From a set of 506 pre-selected radiomic features, the optimal subset resulting on the best discriminative accuracy of the RF classifier consisted of 67 features. The RF classifier was well calibrated (Log Loss 0.296, ECE 0.125) and achieved an accuracy of 88% and a ROC AUC of 0.96. The SHAP analysis revealed that higher values of Wavelet-LLH First-order Mean and Median were associated with ORN of the jaw (ORNJ). Conversely, higher Exponential GLDM Dependence Entropy and lower Square First-order Kurtosis were more characteristic of normal mandibular tissue. Conclusion: This study successfully developed a CECT-based radiomics model for differentiating ORNJ from healthy mandibular tissue in HNC patients after RT. Future work will focus on the detection of subclinical ORNJ regions to guide earlier interventions.
Identifiers
PMID39314948
PMCPMC11419222
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390